Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Halo Measurements in Simulated Multifocal Intraocular Lenses

  • Papadogiannis, Petros
  • Rodríguez-López, Víctor
  • Varea, Alejandra
  • Chorrero, Diego
  • Sawides, L.
  • Dorronsoro, Carlos
  • Castro, Alberto de
To quantify the halo size produced by simulated multifocal and extended depth of focus (EDOF) intraocular lenses (IOLs) using a novel psychophysical method, and to compare the results with an established halo assessment tool, computational simulations, and subjective bothersomeness scores., Supported by Spanish State Research Agency CPP2021-008388, CPP2024-011467, PID2023-152641OA-I00; La Caixa Foundation ID100010434 LCF/TR/CI22/52660002, LCF/TR/CI24/56010018; Community of Madrid IND2023/BMD-27723, IND2024/BDM-35095., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Predictions of Through-Focus Performance of Presbyopia-Correcting Intraocular Lenses in Presbyopic Subjects Using a Visual Simulator

  • Papadogiannis, Petros
  • Barcala, Xoana
  • Sisó-Fuertes, Irene
  • Zaytouny, Amal
  • Sawides, L.
  • Dorronsoro, Carlos
  • Marcos, Susana
To validate whether visual simulations of multifocal intraocular lenses and extended depth of focus (EDOF) intraocular lenses (IOLs) in phakic presbyopes replicate postoperative vision, and to compare performance across these lenses in the same subject., Financial support – Ministerio de Ciencia, Innnovación y Universidades CPP2021-008388, PID2023-152641OA-I00, PID2020-115191RB-I00; Grants – RETOS CPP2021-008388; Royalties – 2EyesVision, PhysIOL BVI, Plenoptika; Travel expenses – 2EyesVision; Patents – P201232043, P201331436, P201531397; Participation on a Data Safety Monitoring Board – 2EyesVision; Leadership – 2EyesVision; Stock and receipt of equipment – 2EyesVision., Financial support – PID2023-152641OA-I00 from Ministerio de Ciencia, Innnovación y Universidades; Grants –RYC2021-033355-I, Ministerio de ciencia e Innovación, IND2023/BMD-27723, Comunidad de Madrid; Leadership – Instituto de Óptica, CSIC; Stock – 2EyesVision., Financial support – Ministerio de Ciencia, Innnovación y Universidades CPP2021-008388, PID2023-152641OA-I00, PID2020-115191RB-I00; Grants – Empire State Development Funds, New York State, Center for Emerging and Innovative Science, Empire State Development Funds, New York State, Center of Excellence in Data Science, National Eye Institute, National Institutes of Health, Research to Prevent Blindness, Zeiss, Stuart Therapeutics, Clerio Vision Inc, Bausch and Lomb, Alcon, CooperVision; Royalties – 2EyesVision, PhysIOL BVI, Plenoptika; Consultant – 2Eyesvision, Adaptilens, AzaleaVision, Hoya; Honoraria – National Academies of Sciences, Elsevier; Travel expenses – 2EyesVision, National Academies of Sciences, European Society for Cataract and Refractive Surgery, Optica; Patents – P201232043, P201331436, P201531397, UR: 2-25038-PROV, UR: 2-25050-PROV; Participation on a Data Safety Monitoring Board – 2EyesVision, Azalea, Hoya; Stock – 2EyesVision, Plenoptika; Receipt of equipment – 2EyesVision, Stuart Therapeutics, Reality Labs. Supported by the Ministerio de Ciencia e Innovación, Spain (CPP2021-008388, PID2023-152641OA-I00, and PID2020-115191RB-I00). The funding organizations had no role in the design or conduct of this research., Peer reviewed